AJP Legacy Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol 197: 580-584, 1959;
0002-9513/59 $5.00
This Article
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paul, M. F.
Right arrow Articles by Nohle, E. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paul, M. F.
Right arrow Articles by Nohle, E. G.

Renal excretion of nitrofurantoin (Furadantin)

Mary F. Paul 1, Raymond C. Bender 1, and Esther G. Nohle 1

1 Section of Biology, Eaton Laboratories, Division of the Norwich Pharmacal Company, Norwich, New York

Renal clearance of nitrofurantoin at various plasma levels was determined in the white rat. The clearance ratios (nitrofurantoin/inulin) exhibited a curvilinear relationship with the plasma level of the drug. The excretion of nitrofurantoin was found to be dependent upon the three following factors: glomerular filtration, tubular secretion and tubular reabsorption. The clearance of nitrofurantoin was not affected by urine flow nor by concurrent PAH administration. It was increased by acetazolamide and decreased slightly by probenecid. Thirty to forty per cent of the dose was recovered in the urine of rats or dogs after either per oral or intravenous administration. Rapid distribution of the drug was indicated by low plasma concentrations following intravenous administration.

Submitted on March 12, 1959







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 1959 by the American Physiological Society.